Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Treatment with Tumor Treating Fields triggers downstream anti-tumor cell response, study finds

Novocure announced that a new study published in the Journal of Clinical Investigation (JCI) finds treatment with Tumor Treating Fields (TTFields) mediated cell disruption activates the immune system and triggers an anti-tumor cell response that may be effectively used together with existing immunotherapy approaches in the treatment of solid tumors, with limited systemic toxicity.

25 Feb 2022

International Aspirin Foundation publishes a report on the work of highly commended investigators

The International Aspirin Foundation has published a report of the Winner and Highly Commended awardees, present at the prestigious Emerging Aspirin Investigator Award Ceremony.

18 Feb 2022

Researchers discover how ovarian cancer hides from the body's immune system

Researchers at the University of Helsinki discovered how ovarian cancer hides from the body's immune system. The findings will help develop novel precision therapies for ovarian cancer, a common and aggressive cancer type.

12 Feb 2022

30-year-old cancer drug could get another shot, study says

A study by Virginia Commonwealth University Massey Cancer Center researchers published in today's print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer, which is the most aggressive form of breast cancer and has few targeted therapies.

9 Feb 2022

Drug used to treat skin and lung cancers slows the progression of ovarian cancer sub-type

A drug currently used to treat skin and lung cancers has been found to slow the progression of a form of ovarian cancer and increase the number of patients who respond to treatment, a clinical trial has found.

4 Feb 2022

Novel test uses cervical screening samples to detect breast and ovarian cancer

A new revolutionary test for detecting ovarian and breast cancer, which could potentially measure future cancer risk, is being developed by researchers from UCL's Institute for Women's Health.

2 Feb 2022

Weight loss by overweight and obese people associated with reduced risk of colorectal adenoma

A new paper in JNCI Cancer Spectrum, published by Oxford University Press, indicates that overweight and obese people who lose weight may reduce their chances of later developing colorectal adenoma – a type of benign growth or polyp in the colon or rectum that could lead to colorectal cancer.

1 Feb 2022

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Death rates from ovarian cancer are predicted to fall by 17% in the UK and by 7% in EU countries in 2022 compared to 2017, according to new research published in the leading cancer journal Annals of Oncology today (Wednesday).

27 Jan 2022

Pilot human trial uses new falloposcope device to capture images of fallopian tubes

Due to a lack of effective screening and diagnostic tools, more than three-fourths of ovarian cancer cases are not found until the cancer is in an advanced stage.

22 Jan 2022

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

A new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for developing therapeutics that target Epstein-Barr virus (EBV).

19 Jan 2022

Breastfeeding linked to reduced cardiovascular disease risk in mothers

Women who breastfed were less likely to develop heart disease or a stroke, or die from cardiovascular disease than women who did not breastfeed, according to a meta-analysis published today in a pregnancy spotlight issue of the Journal of the American Heart Association (JAHA), an open access, peer-reviewed journal of the American Heart Association.

11 Jan 2022

Human iPSC-derived fallopian tube organoids reveal the origins of common ovarian cancer

Stem cell scientists have revealed the origins of a common ovarian cancer by modeling fallopian tube tissues, allowing them to characterize how a genetic mutation puts women at high risk for this cancer.

29 Dec 2021

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

A team of scientists led by the University of Michigan Health Rogel Cancer Center has found that a class of U.S. Food and Drug Administration-approved drugs can effectively stop a highly aggressive type of uterine cancer in its tracks, paving a quick path toward new treatment strategies for a deadly cancer with limited therapeutic options.

17 Dec 2021

Chemicals from certain personal care products may impact maternal hormone levels during pregnancy

Use of certain personal care products during pregnancy may impact maternal hormone levels, according to a new Rutgers study.

11 Dec 2021

Bilateral salpingo-oophorectomy may have risks for younger women, but safe for post-menopausal patients

A study of over 200,500 women who had a hysterectomy for non-cancerous reasons found an increased risk of death in women under 50 years of age when the ovaries and fallopian tubes were also removed during the surgery. The same association was not found in women over 50.

9 Dec 2021

Cancer registry offers a better understanding of ovarian granulosa cell tumors

Examination of Japanese cases of gynecological cancer offers a better understanding of the profile of a rare ovarian tumor and could change treatment guidelines.

4 Dec 2021

Study identifies two genes that play key role in protecting ovarian cancer from the immune system

Immunotherapies have shown striking clinical benefit in the treatment of many cancers, especially when used in combination with chemotherapy.

30 Nov 2021

Imaging drug that illuminates ovarian cancer tissue when exposed to fluorescent light gets FDA approval

The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.

30 Nov 2021

Red blood cell distribution width as a biomarker for COVID-19

A review highlights the prospects and challenges of RDW as a predictive biomarker for viral infections, with a special focus on COVID-19 and hepatitis.

22 Nov 2021

New test enables patient-specific monitoring and treatment for ovarian cancer

Around 870 cases of ovarian cancer are reported in Belgium every year. Most of these patients are treated with surgical interventions and/or chemotherapy.

18 Nov 2021

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Treatment with Tumor Treating Fields triggers downstream anti-tumor cell response, study finds

International Aspirin Foundation publishes a report on the work of highly commended investigators

Researchers discover how ovarian cancer hides from the body's immune system

30-year-old cancer drug could get another shot, study says

Drug used to treat skin and lung cancers slows the progression of ovarian cancer sub-type

Novel test uses cervical screening samples to detect breast and ovarian cancer

Weight loss by overweight and obese people associated with reduced risk of colorectal adenoma

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Pilot human trial uses new falloposcope device to capture images of fallopian tubes

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

Breastfeeding linked to reduced cardiovascular disease risk in mothers

Human iPSC-derived fallopian tube organoids reveal the origins of common ovarian cancer

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

Chemicals from certain personal care products may impact maternal hormone levels during pregnancy

Bilateral salpingo-oophorectomy may have risks for younger women, but safe for post-menopausal patients

Cancer registry offers a better understanding of ovarian granulosa cell tumors

Study identifies two genes that play key role in protecting ovarian cancer from the immune system

Imaging drug that illuminates ovarian cancer tissue when exposed to fluorescent light gets FDA approval

Red blood cell distribution width as a biomarker for COVID-19

New test enables patient-specific monitoring and treatment for ovarian cancer

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in